Category: Blog
-

Making changes to my Low Yield Portfolio
While I was in the mood to make changes I took a look at some stocks that profited pretty well in my Low Yield Portfolio and decided to take those profits and put the money into some higher yielding stocks. Here are the stocks where I took profits: Archer-Daniels-Midland (ADM) Albemarle (ALB) Artesian Resources (ARTNA)…
-

Profit taking to take advantage of some losses
Yesterday I wrote how I closed out positions in two PIMCO funds. Specifically I closed out symbols PCKTX and PONPX. The money from those funds went into two closed end funds also from PIMCO. Those symbols are PCN and PFN. You can reference yesterday’s post for more details. The value of those funds declined significantly…
-

Making changes to my Medium Yield Portfolio
I made an investment last year into PIMCO StocksPlus Small Fund (PCKTX). I didn’t understand it much (that should have been my first clue to not invest) but the dividend yield was around 17% at the time and I decided to take the plunge. I knew full well a dividend of that size would mean…
-

Walgreens drops plans to unload Boots due to inadequate bids
The Deerfield, Ill., pharmacy chain, which launched a review of its options for the businesses in January, said Tuesday that it received significant interest from prospective buyers but that market conditions put a severe crimp on financing availability for buyers. As such, no bidder was able to make an offer that adequately reflects the potential…
-

Chasing the Yield Podcast on Hiatus
Chasing the Yield is on hiatus while I work on some other projects and work on changing the format. After 52 episodes, 3 of which I didn’t have time to finish so I used a computer voice, I was bored with the format. I will see if I can come up with something that entertains…
-
FDA to remove Juul e-cigarettes from U.S. market in blow to Altria
Altria (MO) has a current dividend yield of 8.67% and is rated as “Borderline Safe” by SimplySafeDividends. I hold MO in my Low Yield Portfolio. In total MO is 0.6% of my portfolio. The FDA could announce its decision as early as Wednesday, the people said. The marketing denial order would follow a nearly two-year…
